Research graph
References from A Study on the Correlation Between Clinical Features of Chronic Relapsing Inflammatory Optic Neuropathy and Myelin Oligodendrocyte Glycoprotein Antibodies. Local targets link to admitted publications; unresolved targets remain external evidence.
[Chronic relapsing inflammatory optic neuropathy: a literature review]
2019 · External reference
Recurrent optic neuritis as the initial symptom in demyelinating diseases
10.3988/jcn.2018.14.3.351 · 2018 · External reference
Disease course of chronic relapsing inflammatory optic neuropathy (CRION) in a single care center
10.1590/0004-282x-anp-2021-0157 · 2022 · External reference
Treatment and relapse prevention of typical and atypical optic neuritis
10.3390/ijms23179769 · 2022 · External reference
Variation in evolving optic neuritis
10.1097/wno.0000000000001310 · 2021 · External reference
Inflammatory optic neuritis: from multiple sclerosis to neuromyelitis optica
10.3109/01658107.2013.804232 · 2013 · External reference
Relapsing optic neuritis: a multicentre study of 62 patients
10.1177/1352458513510223 · 2014 · External reference
Chronic relapsing inflammatory optic neuropathy: a systematic review of 122 cases reported
10.1007/s00415-013-6957-4 · 2014 · External reference
Pediatric neuromyelitis optica spectrum disorders
10.1007/s11940-018-0502-9 · 2018 · External reference
Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination
10.1136/jnnp-2017-316880 · 2018 · External reference
Diagnosis and treatment of anti-myelin oligodendrocyte glycoprotein antibody positive optic neuritis
10.1007/s10384-018-0561-1 · 2018 · External reference
A longitudinal comparison of the recovery patterns of optic neuritis with MOG antibody-seropositive and AQP4 antibody-seropositive or -Seronegative for both antibodies
10.1155/2022/4951491 · 2022 · External reference
Clinical feature and disease outcome in patients with myelin oligodendrocyte glycoprotein antibody-associated disorder: a Chinese study
10.1136/jnnp-2022-330901 · 2023 · External reference
Pathogenesis, clinical features, and treatment of patients with myelin oligodendrocyte glycoprotein (MOG) autoantibody-associated disorders focusing on optic neuritis with consideration of autoantibody-binding sites: a review
10.3390/ijms241713368 · 2023 · External reference
Antibodies to myelin oligodendrocyte glycoprotein in chronic relapsing inflammatory optic neuropathy
10.1136/bjophthalmol-2018-313142 · 2019 · External reference
Aquaporin-4 and myelin oligodendrocyte glycoprotein autoantibody status predict outcome of recurrent optic neuritis
10.1016/j.ophtha.2018.03.041 · 2018 · External reference
Anti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritis
10.1212/nxi.0000000000000131 · 2015 · External reference
Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies
10.1186/s12974-018-1335-x · 2018 · External reference
Chronic relapsing inflammatory optic neuropathy: a systematic review of 122 cases reported
10.1007/s00415-013-6957-4 · ExternalCitation · doi-reference
Diagnosis and treatment of anti-myelin oligodendrocyte glycoprotein antibody positive optic neuritis
10.1007/s10384-018-0561-1 · ExternalCitation · doi-reference
Pediatric neuromyelitis optica spectrum disorders
10.1007/s11940-018-0502-9 · ExternalCitation · doi-reference
Aquaporin-4 and myelin oligodendrocyte glycoprotein autoantibody status predict outcome of recurrent optic neuritis
10.1016/j.ophtha.2018.03.041 · ExternalCitation · doi-reference
Variation in evolving optic neuritis
10.1097/wno.0000000000001310 · ExternalCitation · doi-reference
Antibodies to myelin oligodendrocyte glycoprotein in chronic relapsing inflammatory optic neuropathy
10.1136/bjophthalmol-2018-313142 · ExternalCitation · doi-reference
Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination
10.1136/jnnp-2017-316880 · ExternalCitation · doi-reference
Clinical feature and disease outcome in patients with myelin oligodendrocyte glycoprotein antibody-associated disorder: a Chinese study
10.1136/jnnp-2022-330901 · ExternalCitation · doi-reference
A longitudinal comparison of the recovery patterns of optic neuritis with MOG antibody-seropositive and AQP4 antibody-seropositive or -Seronegative for both antibodies
10.1155/2022/4951491 · ExternalCitation · doi-reference
Relapsing optic neuritis: a multicentre study of 62 patients
10.1177/1352458513510223 · ExternalCitation · doi-reference
Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies
10.1186/s12974-018-1335-x · ExternalCitation · doi-reference
Anti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritis
10.1212/nxi.0000000000000131 · ExternalCitation · doi-reference
Disease course of chronic relapsing inflammatory optic neuropathy (CRION) in a single care center
10.1590/0004-282x-anp-2021-0157 · ExternalCitation · doi-reference
Inflammatory optic neuritis: from multiple sclerosis to neuromyelitis optica
10.3109/01658107.2013.804232 · ExternalCitation · doi-reference
Treatment and relapse prevention of typical and atypical optic neuritis
10.3390/ijms23179769 · ExternalCitation · doi-reference
Pathogenesis, clinical features, and treatment of patients with myelin oligodendrocyte glycoprotein (MOG) autoantibody-associated disorders focusing on optic neuritis with consideration of autoantibody-binding sites: a review
10.3390/ijms241713368 · ExternalCitation · doi-reference
Recurrent optic neuritis as the initial symptom in demyelinating diseases
10.3988/jcn.2018.14.3.351 · ExternalCitation · doi-reference
